PGNY
USDProgyny Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$18.280
Máximo
$18.840
Mínimo
$18.030
Volume
0.61M
Fundamentos da empresa
Capitalização de mercado
1.6B
Setor
Healthcare Plans
País
United States
Estatísticas de negociação
Volume médio
1.31M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Relatório de análise de IA
Última atualização: 3/11/2025PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders
What's Happening With Progyny Right Now
Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash
Notícias relacionadas
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs
Transcarent Experience Store Expansion: More Options for Women's Health
Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the
Progyny CEO Named World Economic Forum Champion for Women's Health
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a
Previsão de IABeta
Recomendação de IA
Atualizado em: 4/11/2025, 17:26
64.3% Confiança
Risco e negociação
Ponto de entrada
$18.21
Tomar lucro
$19.66
Parar perda
$16.58
Fatores-chave
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.